Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression

J Pathol. 2011 Jul;224(3):309-21. doi: 10.1002/path.2896. Epub 2011 May 19.

Abstract

Patients carrying heterozygous germline truncating mutations in the CYLD gene develop multiple primary hair follicle-related tumours. A highly patterned tumour, termed cylindroma, and a highly disorganized tumour, termed spiradenoma, may both develop in the same patient. Furthermore, histological features of both tumour types have been described within the same tumour specimen. We used three-dimensional computer-aided reconstruction of these tumours to demonstrate contiguous growth of cylindromas into spiradenomas, thus suggesting a transition between the two tumour types. To explore factors that may influence cutaneous tumour patterning, genome-wide transcriptomic analysis of 32 CYLD-defective tumours was performed. Overexpression of the Wnt/β-catenin signalling pathway was observed relative to normal perilesional tissue. Morphometric analysis was used to investigate the relationship between Wnt pathway-related gene expression and tumour organization. This revealed an association between reduced Dickkopf 2 (DKK2-a negative regulator of the Wnt/β-catenin signalling pathway) expression and loss of tumour patterning. Reduced DKK2 expression was associated with methylation of the DKK2 gene promoter in the majority of tumour samples assayed. RNA interference-mediated silencing of DKK2 expression in cylindroma primary cell cultures caused an increase in colony formation, cell viability, and anchorage-independent growth. Using these data, we propose a model where epigenetic programming may influence tumour patterning in patients with CYLD mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma, Sweat Gland / genetics
  • Adenoma, Sweat Gland / metabolism*
  • Adenoma, Sweat Gland / pathology
  • Carcinoma, Adenoid Cystic / genetics
  • Carcinoma, Adenoid Cystic / metabolism*
  • Carcinoma, Adenoid Cystic / pathology
  • Cell Proliferation
  • DNA Methylation
  • DNA, Neoplasm / genetics
  • Deubiquitinating Enzyme CYLD
  • Disease Progression
  • Gene Knockdown Techniques
  • Genome-Wide Association Study / methods
  • Germ-Line Mutation
  • Humans
  • Imaging, Three-Dimensional
  • Intercellular Signaling Peptides and Proteins / genetics
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Neoplasm Proteins / metabolism
  • Phenotype
  • Promoter Regions, Genetic
  • Signal Transduction
  • Skin Neoplasms / genetics
  • Skin Neoplasms / metabolism*
  • Skin Neoplasms / pathology
  • Sweat Gland Neoplasms / genetics
  • Sweat Gland Neoplasms / metabolism
  • Sweat Gland Neoplasms / pathology
  • Tumor Cells, Cultured
  • Tumor Suppressor Proteins / genetics*
  • Wnt Proteins / metabolism
  • beta Catenin / metabolism

Substances

  • CTNNB1 protein, human
  • DKK2 protein, human
  • DNA, Neoplasm
  • Intercellular Signaling Peptides and Proteins
  • Neoplasm Proteins
  • Tumor Suppressor Proteins
  • Wnt Proteins
  • beta Catenin
  • CYLD protein, human
  • Deubiquitinating Enzyme CYLD